According to the Shortage of Pancreatic enzyme replacement therapy (PERT) National Patient Safety Alert (NPSA) published on 18 December 2024, Creon® will remain in limited supply until 2026 and alternatives such as Nutrizym® 22 capsules and Pancrex V® capsules and powder are intermittently available but are unable to fully cover the gap in supply. One of the [...]
The post Supply of unlicensed PERT preparations appeared first on Community Pharmacy England.
Community pharmacies are reminded that Inclisiran (Leqvio®) 284mg/1.5ml solution for injection pre-filled syringe is available to order from the nominated wholesaler AAH UK at a nominal charge of £45 per pack for supply against NHS prescriptions, as agreed within the commercial agreement between Novartis Pharmaceuticals UK Ltd and NHS England. A summary of the current [...]
The post Inclisiran (Leqvio®) orders for NHS prescriptions – check your invoices appeared first on Community Pharmacy England.
Updated 22/01/2025 – This recall notification has been updated since its initial publication on 21 January 2025 to include the correct batch information for several batches. Bells Healthcare erroneously provided incorrect information pertaining to the expiry date of several batches and have ensured that all other batch information is correct. Please ensure that appropriate action [...]
The post MHRA Class 2 Medicines Recall: Tesco Health Dry Cough Relief 200ml, Asda Strong Dry Tickly Cough 200ml, Almus Dry Cough Relief & Bells Dual Action Dry Cough- Updated appeared first on Community Pharmacy England.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Hydrocortisone sodium phosphate 100mg/1ml solution for injection ampoules. MSN/2025/004 Tier 2 – medium impact Date of issue: 20th January 2025 Hydrocortisone sodium phosphate 100mg/1ml solution for injection ampoules are in limited supply with stock exhaustion anticipated by late March 2025; anticipated [...]
The post Medicine Supply Notification: Hydrocortisone sodium phosphate 100mg/1ml solution for injection ampoules appeared first on Community Pharmacy England.
MHRA Class 4 Medicines Defect Notification: Irbesartan 150 mg and 300 mg film-coated tablets (Jubilant Pharmaceuticals NV) Drug alert number: EL(25)A/02 Date issued: 13 January 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Irbesartan 150 mg and 300 mg film-coated tablets (Jubilant Pharmaceuticals NV) [...]
The post MHRA Class 4 Medicines Defect Notification: Irbesartan 150 mg and 300 mg film-coated tablets (Jubilant Pharmaceuticals NV) appeared first on Community Pharmacy England.
Recent Comments